Edition:
United Kingdom

AzurRx BioPharma Inc (AZRX.OQ)

AZRX.OQ on NASDAQ Stock Exchange Capital Market

2.47USD
18 Apr 2019
Change (% chg)

-- (--)
Prev Close
$2.47
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
20,405
52-wk High
$3.75
52-wk Low
$1.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.235
Sep '18 0.00 -0.152
Jun '18 0.00 -0.216
Mar '18 0.00 -0.292
FY 2017 Dec '17 0.00 -0.215
Sep '17 0.00 -0.279
Jun '17 0.00 -0.265
Mar '17 0.00 -0.292
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Year Ending Dec-20 3 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-19 3 -0.18 -0.17 -0.19 --
Quarter Ending Sep-19 3 -0.15 -0.13 -0.16 --
Year Ending Dec-19 4 -0.69 -0.65 -0.74 -0.64
Year Ending Dec-20 5 -0.61 -0.51 -0.74 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.30 32.55
P/E High - Last 5 Yrs. -- 43.17 48.10
P/E Low - Last 5 Yrs. -- 22.71 23.42
Beta -- 0.86 0.87
Price to Sales (TTM) -- 6.59 8.39
Price to Book (MRQ) 8.59 5.12 5.27
Price to Tangible Book (MRQ) 36.95 5.84 6.74
Price to Cash Flow (TTM) -- 23.07 24.13
% Owned Institutions 5.56 0.87 1.65

Dividends

  Company industry sector
Dividend Yield -- 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 3.99 4.70
Payout Ratio(TTM) -- 42.19 39.61

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.43 13.46
Sales (TTM) vs TTM 1 Yr. Ago -- 6.61 8.04
Sales - 5 Yr. Growth Rate -- 10.48 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago 32.20 45.67 47.73
EPS (TTM) vs TTM 1 Yr. Ago -42.53 -- --
EPS - 5 Yr. Growth Rate -- 9.90 10.46
Capital Spending - 5 Yr. Growth Rate -- 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) 1.97 2.87 2.98
LT Debt to Equity (MRQ) 0.00 8.87 11.32
Total Debt to Equity (MRQ) 14.45 12.86 16.01
Interest Coverage (TTM) -2.14 32.48 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 52.10 52.41
Gross Margin - 5 Yr. Avg. -- 49.66 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.26 12.41
Operating Margin (TTM) -- 13.53 5.77
Operating Margin - 5 Yr. Avg. -- 13.69 8.01
Pre-Tax Margin (TTM) -- 11.88 4.79
Pre-Tax Margin - 5 Yr. Avg. -- 14.09 8.29
Net Profit Margin (TTM) -- 8.79 1.52
Net Profit Margin - 5 Yr. Avg. -- 10.58 4.70
Effective Tax Rate (TTM) -- 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 928,597,997 820,412,980
Net Income/Employee (TTM) -- 105,162,136 92,866,230
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.41
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -186.57 10.98 10.60
Return on Assets - 5 Yr. Avg. -- 12.41 11.78
Return on Investment (TTM) -- 14.23 13.83
Return on Investment - 5 Yr. Avg. -- 16.18 15.32
Return on Equity (TTM) -- 15.46 15.25
Return on Equity - 5 Yr. Avg. -- 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -264.31 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AzurRx BioPharma Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -19.33 -22.11 4 29
13 Week -2.45 -7.20 47 42
26 Week -9.01 -15.93 40 44
52 Week -- -- -- 11
YTD -24.26 -33.49 19 38
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.84%
# of Holders: 18
Total Shares Held: 2,750,722
3 Mo. Net Change: -10,523
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 2
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.